RUEN
Contact

Industry route

MedTech, Pharma & Healthcare: entering the Bangladesh market

For MedTech, Pharma and Health IT in Bangladesh we first fix intended use and the buyer, then build a regulatory map (DGDA and related authorities), a shortlist of importers/distributors, and a pilot with a clinic or diagnostics network. The goal is a Go / Pivot / No-go decision before major registration and local-service spend.

Get a project assessment for MedTech, Pharma & Healthcare

Products and use cases

  • medical devices and consumables;
  • pharmaceuticals and related solutions;
  • Health IT, telemedicine, lab and clinical systems;
  • CRM/distribution and training (CME/LMS) for the channel.

Buyers

  • pharma companies and importers;
  • distributors and service partners;
  • clinics, diagnostics networks, medical universities;
  • industry associations.

Entry models

  • local importer / registration holder;
  • registration partner + distribution;
  • pilot with a clinic or university;
  • B2B licensing for Health IT.

Regulatory and operating map

DGDA and sector authorities by product category; ethics, clinical questions and patient data are checked separately. Claims and classification are fixed before outreach.

Documents for diagnostic

  • product description and intended use;
  • classification, certificates and dossier;
  • clinical data / evidence pack;
  • IFU, labelling, data-flow and cybersecurity;
  • service and training model.

Process: from fit to pilot

  1. 01Fit check
  2. 02Regulatory map
  3. 03Partner shortlist
  4. 04Pilot design
  5. 05Go / No-go

Risks

  • incorrect product classification;
  • registration timelines and unconfirmed claims;
  • data/privacy and missing local service;
  • partner without operational capability.

Go / Pivot / No-go

  • Go — there is a buyer + a clear regulatory route + a partner candidate;
  • Pivot — change the entry model or segment;
  • No-go — critical registration/evidence blocker without a realistic timeline.

Frequently asked questions

Is registration required before first clinic outreach?

Not always. We first clarify the category and allowed pilot formats. Regulator filing is a separate step after diagnostic.

Can you guarantee DGDA approval?

No. We deliver a requirements map, partners and a pilot plan. Government timelines and decisions are not guaranteed.

Get a project assessment for MedTech, Pharma & HealthcareRelated serviceAll industries